Despite Big Pharma’s claim that high-cost medicines are the price society must pay for innovation, recent research provides ample evidence that overpriced medicines are not necessary for the industry to find cures or revolutionize. Rather, high-cost and low-quality medicines are the price patients pay for an industry that prioritizes profit-seeking over public health. Like all
Tomorrow at Walmart’s shareholders’ meeting in Bentonville, Arkansas, Walmart workers will call out America’s broken corporate governance system and propose that Walmart workers be included on its board of directors. Walmart associate Cat Davis will be joined by Senator Bernie Sanders (I-VT), who will speak on behalf of workers’ right to participate in corporate decision-making.
In “The Cost of Capture: How the Pharmaceutical Industry Has Corrupted Policymakers and Harmed Patients,” Roosevelt Fellow Julie Margetta Morgan and Advocacy Associate Devin Duffy explore how drug companies influence policymakers and what this means for patients, the American health care system, and our economy. One of a series on Big Pharma, this issue brief
FOR IMMEDIATE RELEASE: May 22, 2019 CONTACT: Ariela Weinberger, firstname.lastname@example.org Capturing the Government: Big Pharma’s Take Over of Policymaking New brief explores how drug companies influence policymakers and the resulting harm in patient outcomes Today, the Roosevelt Institute released the issue brief, “The Cost of Capture: How the Pharmaceutical Industry has Corrupted Policy Makers and
Digital platforms play a central role in the economy and Americans’ everyday lives. Each platform has distinct characteristics, but specific concerns about their dominance in the marketplace—and on key parts of daily life—have grown in recent years. In The Case for the Digital Platform Act: Market Structure and Regulation of Digital Platforms, Public Knowledge Senior Vice
The US economy suffers from a market power problem that has invaded many sectors, including health care, telecommunications, and technology. As firms become more powerful, they are able to profit by taking advantage of other economic stakeholders rather than growing the overall economic pie. Competition as America once knew it—firms working to provide better goods
A New 21st Century Policy Agenda: Roosevelt Report Proposes Changing the Balance of Power in the Economy
FOR IMMEDIATE RELEASE: April 10, 2019 CONTACT: Ariela Weinberger, email@example.com A New 21st Century Policy Agenda: Roosevelt Report Proposes Changing the Balance of Power in the Economy At Washington DC launch event, Roosevelt experts presented a new approach to policymaking, with a keynote from former Georgia House Minority Leader Stacey Abrams WASHINGTON, DC — Today,
FOR IMMEDIATE RELEASE: April 10, 2019 CONTACT: Ariela Weinberger, firstname.lastname@example.org Roosevelt Institute Releases New Policy Report on Tackling 21st Century Economic Challenges New report offers bold approach to policymaking: curbing concentrated power and reclaiming public power in our economy and political system NEW YORK, NY — Today, the Roosevelt Institute, a New York-based think tank
New Rules for the 21st Century: Corporate Power, Public Power, and the Future of the American Economy
America’s political landscape and economic thinking are shifting. The 2016 election—and the rise of powerful movements over the past decade—has shown us that Americans are calling for change. They want a diagnosis of our economy to help make sense of what’s gone wrong and to suggest ways to make things better. In New Rules for
This blog post is based off of remarks given at “Wall Street and the Next Recession: Protecting Main Street in the Next Economic Downturn,” an event co-sponsored by Americans for Financial Reform and the Center for Popular Democracy at the US Senate. One thing is certain about markets: they go up and they go down.